Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Nestin is a potential mediator of malignancy in human neuroblastoma cells.

Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA.

J Biol Chem. 2004 Jul 2;279(27):27994-9. Epub 2004 Apr 26.

2.

Identification and isolation of hematopoietic stem cells.

Wognum AW, Eaves AC, Thomas TE.

Arch Med Res. 2003 Nov-Dec;34(6):461-75. Review.

PMID:
14734086
3.

Cancerous stem cells can arise from pediatric brain tumors.

Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83. Epub 2003 Nov 26.

4.

A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors.

Ross RA, Biedler JL, Spengler BA.

Cancer Lett. 2003 Jul 18;197(1-2):35-9. Review.

PMID:
12880957
5.

Neuroblastoma: biological insights into a clinical enigma.

Brodeur GM.

Nat Rev Cancer. 2003 Mar;3(3):203-16. Review.

PMID:
12612655
6.

Molecular identification of distinct neurogenic and melanogenic neural crest sublineages.

Luo R, Gao J, Wehrle-Haller B, Henion PD.

Development. 2003 Jan;130(2):321-30.

7.

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK.

Cancer. 2001 Nov 1;92(9):2451-61.

PMID:
11745303
8.

Stem cells, cancer, and cancer stem cells.

Reya T, Morrison SJ, Clarke MF, Weissman IL.

Nature. 2001 Nov 1;414(6859):105-11. Review.

9.

Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.

Mora J, Cheung NK, Juan G, Illei P, Cheung I, Akram M, Chi S, Ladanyi M, Cordon-Cardo C, Gerald WL.

Cancer Res. 2001 Sep 15;61(18):6892-8.

10.

Direct isolation of human central nervous system stem cells.

Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL.

Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14720-5.

11.

Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases.

Valent A, Bénard J, Vénuat AM, Silva J, Duverger A, Duarte N, Hartmann O, Spengler BA, Bernheim A.

Cancer Genet Cytogenet. 1999 Jul 15;112(2):124-9.

PMID:
10686938
12.

The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells.

Nikolopoulos SN, Spengler BA, Kisselbach K, Evans AE, Biedler JL, Ross RA.

Oncogene. 2000 Jan 20;19(3):380-6.

13.
14.
15.

Neuroblastoma: biology and therapy.

Matthay KK.

Oncology (Williston Park). 1997 Dec;11(12):1857-66; discussion 1869-72, 1875. Review.

PMID:
9436190
16.

Biology and treatment of neuroblastoma.

Castleberry RP.

Pediatr Clin North Am. 1997 Aug;44(4):919-37. Review.

PMID:
9286292
18.

Human neuroblastoma cell lines that express N-myc without gene amplification.

Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, Reynolds CP.

Cancer. 1993 Dec 1;72(11):3346-54.

19.

Human neuroblastoma lines respond differently to diverse differentiation-inducing agents.

Spengler BA, Domènech C, Porubcin M, Biedler JL.

Prog Clin Biol Res. 1994;385:261-7. No abstract available.

PMID:
7972218
20.

Human neuroblastoma I-type cells are malignant neural crest stem cells.

Ross RA, Spengler BA, Domènech C, Porubcin M, Rettig WJ, Biedler JL.

Cell Growth Differ. 1995 Apr;6(4):449-56.

Supplemental Content

Support Center